The guidance they provided as well was way too optimistic. Now we're being fed the delays are norm for the industry. Doh, of course they are, why the company didn't stretch out first dosing guidance until Q2 2025 this year I can't understand given the spectacular 2023 performance.
Under promise over deliver should be the new motto, we've had far too much of the former. A compliance form Wow.
RAC Price at posting:
$1.16 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)